Brief: Hls Therapeutics Announces Updates To Its Credit Agreement
Oct 3 (Reuters) -
* HLS THERAPEUTICS ANNOUNCES UPDATES TO ITS CREDIT AGREEMENT
* HLS THERAPEUTICS INC - MATURITY DATE ON SENIOR SECURED
TERM LOAN
HAS BEEN EXTENDED BY ONE YEAR TO AUGUST 15, 2024
* HLS THERAPEUTICS INC - REQUIRED ANNUAL AMORTIZATION OF
LOAN
VALUE REVERTS BACK TO 5%
Source text for Eikon: ID:nCNWSLZTVa
((Reuters.Briefs@thomsonreuters.com;))
Recent news on HLS Therapeutics
See all newsCanada Research Roundup: CIBC ,HLS Therapeutics, TD Bank Group
Canada's HLS Therapeutics Q1 revenue rises on Vascepa growth, reaffirms 2026 guidance
Canada's HLS Therapeutics Q4 revenue slightly beats on Vascepa strength
Brief: Esperion Partner announces HLS Therapeutics received approval Of NILEMDO for the reduction of LDL-cholesterol in canadians at risk of cardiovascular disease
Brief: HLS Therapeutics announces Health Canada approval of NILEMDO for the reduction of LDL-Cholesterol in Canadians at risk of cardiovascular disease